SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001390478-22-000020
Filing Date
2022-08-11
Accepted
2022-08-11 16:06:44
Documents
66
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sls-20220630.htm   iXBRL 10-Q 1045637
2 EX-31.1 sls-20220630ex311.htm EX-31.1 8301
3 EX-31.2 sls-20220630ex312.htm EX-31.2 8305
4 EX-32.1 sls-20220630ex321.htm EX-32.1 6714
10 sls-20220630_g1.jpg GRAPHIC 30719
  Complete submission text file 0001390478-22-000020.txt   5254462

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sls-20220630.xsd EX-101.SCH 42722
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sls-20220630_cal.xml EX-101.CAL 50771
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sls-20220630_def.xml EX-101.DEF 157765
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sls-20220630_lab.xml EX-101.LAB 482428
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sls-20220630_pre.xml EX-101.PRE 315495
60 EXTRACTED XBRL INSTANCE DOCUMENT sls-20220630_htm.xml XML 834981
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 221155695
SIC: 2834 Pharmaceutical Preparations